Global Modern Manufacturing Execution System Market is estimated to grow at a CAGR of 15.41% over the forecast period :

Pune, India, May 2021, /MRFR Press Release/- Market Research Future published a cooked research report on the Global Modern Manufacturing Execution System Market.

Overview


The modern manufacturing execution system market is anticipated to witness healthy growth from 2017 to 2027, a research report suggests. Growing at a CAGR of 16.1%, the market is projected to reach US$46.3 billion by 2027. The low deployment cost is expected to support the market growth along with increasing industrial automation. As predicted by analysts, high investments will negatively affect the market’s performance from 2017 to 2027. During the forecast period, the market will be supported by the adoption of factory automation technologies and the importance of regulatory compliance.


Costs involved in the maintenance and upgrade on the other hand will challenge lifecycle management applications sector based organizations functioning in the global modern manufacturing execution system market. Analysts have split the market into deployment, discrete industry, region, and component segments based on products and services. Lifecycle management applications based companies have been profiled. Upgrade of manufacturing execution systems is set to affect the global market during the forecast period 2017 to 2027. The report also provides the market’s performance forecasts till 2027. Strategies of lifecycle management applications based companies are studied. The lifecycle management applications sector itself is supported by growing need for real-time visibility as well as increasing demand for industrial automation. During the forecast period 2017 to 2027, the modern manufacturing execution system market is set to witness a health growth across deployment, discrete industry, region, and component segments as well as regional markets.


Market Segmentation


The lifecycle management applications sector has seen growth across deployment, discrete industry, region, and component segments owing to increasing Penetration of MES and high demand across industry verticals. To study the market, analysts have further segmented deployment, discrete industry, region, and component into on-premise, on cloud, and hybrid on the basis of deployment. The market is further segmented into the discrete industry sub segment which is split into aerospace & defense, automotive, electronics, FMCG, medical, others. Additionally, the modern manufacturing execution system market on the basis of components is segmented into software and services.


The segmental analysis presented in the report provides lifecycle management applications field based organizations insights into key growth factors such as the rapidly growing population as well as challenges such as high initial investment the market will face from 2017 to 2027. Increasing penetration of MES in the industrial internet of things (IIOT) and the increasing disposable income are some of the key factors having an influence on lifecycle management applications industry based companies, suggest analysts as per the modern manufacturing execution system market report. But the report also identifies increased IT/OT adoption for manufacturing and supply chain enhancement and early adoption of innovative technologies as major threats companies in lifecycle management applications will face till 2027. 


Access Report Details @ https://www.marketresearchfuture.com/reports/modern-manufacturing-execution-system-market-1094


Regional Overview


Lifecycle management applications market based companies in the modern manufacturing execution system market are functioning across North America, Europe, Asia Pacific, the Middle East, and Africa including the rest of the world. Advancements in technology will be a key growth driver for regional markets. However, workforce investments will turn out to be a threat. For the forecast period 2017 to 2027. Each of these regional markets are studied in the report. Starting from North America, the regional market and lifecycle management applications vertical based companies are spread across the United States, Mexico, and Canada.


The lack of investments in research and development will turn out to be a major challenge from 2017 to 2027. Parts of the European market covered in the report are regional markets spread across the United Kingdom, France, Italy, and Germany. The market in the region will be benefitted by the rising industrialization as well as the surging usage across different industries, suggests the report. Similarly, the lifecycle management applications sector’s segmental analysis for the Asia Pacific region covers India, Japan, China, and others. For the rest of the world, the research report for the modern manufacturing execution system market covers the Middle East and Africa. The global modern manufacturing execution system market forecasts based on the findings are presented for the forecast period till 2027.


Competitive Landscape


The global modern manufacturing execution system market research report brings a comprehensive study of deployment, discrete industry, region, and component market segments, regional analysis, and lifecycle management applications vertical based company details of key players. As the forecast period 2017 to 2027 will bring new opportunities for the market owing to advancements in technology and the growing application areas, the market is set to grow at a compound annual growth rate of 16.1% and is predicted to reach a value of US$46.3 billion by 2027. With SWOT analysis of lifecycle management applications sector based companies and Porter’s Five Force model analysis based findings, and understanding challenges such as the high cost of services and maintenance and an underdeveloped infrastructure, companies in the lifecycle management applications sector can change the way business is done.


Industry News


With the support of Siemens, BioNTech SE converted an existing facility in Marburg, Germany, to produce the Covid-19 vaccine. The active agent has been generated at the manufacturing facility. The building was purchased by BioNTech in the fall of 2020. Initially, the organisation estimated that converting the facility for mRNA vaccine development would take a year, but Siemens and on-site specialists were able to complete the task in just five months. The time it took to incorporate core components of the current Manufacturing Execution System (MES) was slashed in half.